| Line Item | 2024-02-03 | Y/Y |
|---|---|---|
| Revenue | $937.4M | +43.7% |
| Cost of Revenue | $247.0M | +35.2% |
| Gross Profit | $690.4M | +46.9% |
| R&D Expense | $258.6M | +38.0% |
| SG&A Expense | $195.0M | +14.2% |
| Operating Income | -$323.3M | -24.6% |
| Pre-tax Income | -$283.4M | -16.2% |
| Income Tax | $3.3M | -6.8% |
| Net Income | -$286.7M |
| Line Item | 2024-02-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $135.5M | -32.5% |
| Accounts Receivable | $161.8M | +31.7% |
| Inventory | $22.2M | -45.2% |
| Current Assets | $887.0M | -7.4% |
| Total Assets | $1.73B | +7.3% |
| Current Liabilities | $591.8M | +33.8% |
| Total Liabilities | $819.7M | +20.7% |
| Line Item | 2024-02-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.8M | +88.5% |
| Capital Expenditures | $11.0M | -67.0% |
| Investing Cash Flow | -$78.7M | +87.5% |
| Financing Cash Flow | $21.0M | +47.7% |
| Free Cash Flow | -$22.8M | +83.3% |
| -15.9% |
| EPS (Basic) | -$0.54 | -12.5% |
| EPS (Diluted) | -$0.54 | -12.5% |
| Stockholders' Equity |
| $915.1M |
| -2.4% |